About CWA
We didn't set out to build a better distributor. We set out to make the distributor irrelevant.
The medicinal cannabis industry in Australia was built backwards.
Sponsors fought for shelf space. Pharmacies were overwhelmed with reps, conflicting claims, and compliance friction. Prescribers had no neutral source of truth. Patients fell through the gaps.
Everyone was optimising for their own position in the chain. Nobody was optimising for the decision.
Cannabis Warehouse Australia was built to fix that.
To be the clinical intelligence infrastructure of the Australian medicinal cannabis supply chain — agnostic by design, outcomes-driven by default.
We are not a marketplace. We don't take sides. We don't push product. We don't have preferred sponsors.
We are not just a wholesaler. Holding stock and processing orders is the floor, not the ceiling.
We are the decision layer.
The infrastructure that sits between every sponsor and every clinical endpoint in Australia — giving pharmacies frictionless access, giving prescribers sponsor-neutral intelligence, and giving the supply chain a backbone it was missing.
When a pharmacist reorders without friction, a prescriber recommends with confidence, and a patient receives the right product — that's CWA working the way it was designed to.
How we operate
Distribution
Sponsor-neutral. TGA-aware. Same-day metro. One ordering workflow across the full portfolio. No exclusivity contracts. No pressure. Just supply that works.
Clinical Intelligence
The only distributor in Australia with a directly integrated clinical network. What gets prescribed informs what gets stocked. What gets stocked informs what gets prescribed. The loop is closed — and it belongs to no single brand.
Manufacturing
White-label capability, tolling partnerships, and TGA-compliant manufacturing pathways for sponsors who want to move faster without building from scratch.
Clinical intelligence powered by SureCan — our directly integrated clinical network.
Agnosticism is a principle, not a gap.
We believe the best distribution infrastructure serves no master except the patient outcome.
Friction is a clinical risk.
Every compliance headache, every delayed order, every confusing invoice is a barrier between a patient and their medicine. We remove barriers.
Intelligence compounds.
The longer we operate, the more we understand what moves, what works, and what the market actually needs. That knowledge doesn't belong to a brand. It belongs to the network.
The medicinal cannabis industry is still being built. The companies that will matter in ten years are the ones building infrastructure now — not the ones chasing margin today.
That's what we're doing.
Cannabis Warehouse Australia.
Agnostic by design. Clinical by nature.